CNNMoney.com
Companies Economy International Corrections Pre-market Trading After-hours Trading Winners/Losers/Actives Bonds Currencies Commodities World Markets Money Magazine Real Estate Taxes Jobs Ask the Expert Money 101 Autos Mutual Funds The Help Desk Loan Center Best Places to Live Ask the Expert Ultimate Guide to Retirement Retirement Calculators Best Funds Best Places to Retire Fortune Brainstorm Tech Apple 2.0 Blog Big Tech Blog Sectors and Stocks Tech Talk Resource Guide Small Business Makeovers Questions & Answers Small Business Video 100 Best Places to Launch FSB 100 Fortune Small Business Fortune 500 Brainstorm Tech Investing Management C-Suite Rankings Main Create Portfolio Edit Portfolio Create Alerts Edit Alerts
Liberating a Lifesaver
By Daisy Chan

(FORTUNE Small Business) – Every year 340,000 Americans die from sudden cardiac arrest, with about 80% collapsing at home, according to the American Heart Association. Automated external defibrillators (AEDs), which require no training to use and cost around $2,000, could save lives. But if you want an AED, you'll need a prescription—a leftover from the days when defibrillators were large, dangerous machines. That requirement is shackling a potential $800 million market for makers such as Cardiac Science, which produces 25% of all AEDs. Although the Irvine, Calif., company has annual sales of $62 million, it is still in the red. In July, AED giant Philips petitioned the FDA to lift the requirement; as of presstime, the decision was pending. —D.C.